שנה שפה:

Predicting Failure of Nonoperative Treatment for Insertional Achilles Tendinosis



Eliezer Sidon5, James Stenson1,3, Christopher Reb2,4, Joseph Daniel1,3, Sundeep Saini1,3, Mohammed Albana1,3
1 Orthopaedic Surgery, Rowan University School of Osteopathic Medicine, Stratford, NJ, USA
2 Orthopaedic Surgery, University of Florida, Gainesville, FL, USA
3 Department of Orthopaedic Surgery, Rowan University School of Osteopathic Medicine, Stratford, NJ, USA
4 Department of Orthopaedic Surgery, University of Florida, Gainesville, FL, USA
5 Orthopaedic Deptartment, Rabin Medical Center, Israel

Nonoperative treatment for midportion Achilles tendinosis is well defined by the literature. Multiple modalities are described for the management of insertional Achilles pathology, but no consensus exists regarding efficacy. Surgical intervention for insertional stratify patients who would fail nonsurgical management of IAT and thus benefit progressing to surgery. We reviewed the records of 664 patients with IAT. The cohort was 53% male and 80% obese. Mean age was 53.7 years (standard deviation 14.7 years). Average duration of symptoms all 4 parameters, chance of failing conservative treatment was only 55%. Thus, nonoperative was 10.4 months (standard deviation 28 months). Of the parameters collected, 4 were found to correlate with failing nonoperative treatment: visual analog scale, limited ankle range of motion, previous corticosteroid injection, and presence of Achilles tendon enthesophyte. We found that as the number of risk factors increased so did the chance of failing nonoperative treatment. With management should be exhausted until surgery is the only remaining option. However, the presence of one of the aforementioned risk factors can aid a surgeon in the decision to pursue surgery in the appropriate clinical scenario.

העלאת קובץ המאמר או המצגת